These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35907954)

  • 1. Foveal eversion patterns in diabetic macular edema.
    Arrigo A; Saladino A; Aragona E; Amato A; Capone L; Bianco L; Lattanzio R; Bandello F; Battaglia Parodi M
    Sci Rep; 2022 Jul; 12(1):13097. PubMed ID: 35907954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foveal Eversion: A Possible Biomarker of Persistent Diabetic Macular Edema.
    Arrigo A; Aragona E; Capone L; Lattanzio R; Zollet P; Bandello F
    Ophthalmol Ther; 2021 Mar; 10(1):115-126. PubMed ID: 33420954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes in diabetic macular edema switched directly or after a dexamethasone implant to a fluocinolone acetonide intravitreal implant following anti-VEGF treatment.
    Rehak M; Busch C; Unterlauft JD; Jochmann C; Wiedemann P
    Acta Diabetol; 2020 Apr; 57(4):469-478. PubMed ID: 31749051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dril Influences Short-term Visual Outcome after Intravitreal Corticosteroid Injection for Refractory Diabetic Macular Edema.
    Luís ME; Sampaio F; Costa J; Cabral D; Teixeira C; Ferreira JT
    Curr Eye Res; 2021 Sep; 46(9):1378-1386. PubMed ID: 33463388
    [No Abstract]   [Full Text] [Related]  

  • 5. Persistent or Recurrent Diabetic Macular Edema After Fluocinolone Acetonide 0.19 mg Implant: Risk Factors and Management.
    Cicinelli MV; Rabiolo A; Zollet P; Capone L; Lattanzio R; Bandello F
    Am J Ophthalmol; 2020 Jul; 215():14-24. PubMed ID: 32209341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The outcome of fluocinolone acetonide intravitreal implant is predicted by the response to dexamethasone implant in diabetic macular oedema.
    Cicinelli MV; Rosenblatt A; Grosso D; Zollet P; Capone L; Rabiolo A; Lattanzio R; Loewenstein A; Bandello F;
    Eye (Lond); 2021 Dec; 35(12):3232-3242. PubMed ID: 33479485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-Year Safety and Efficacy of the 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: The PALADIN Study.
    Singer MA; Sheth V; Mansour SE; Coughlin B; Gonzalez VH
    Ophthalmology; 2022 Jun; 129(6):605-613. PubMed ID: 35063472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Diabetic Macular Edema with Multiple Dexamethasone Intravitreal Implants: Evidence from Real-Life Experience.
    De Geronimo D; Giorno P; Scarinci F; Boninfante A; Varano M; Parravano M
    Ophthalmologica; 2020; 243(6):413-419. PubMed ID: 31760387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone intravitreal implant in vitrectomized versus nonvitrectomized eyes for treatment of patients with persistent diabetic macular edema.
    Medeiros MD; Alkabes M; Navarro R; Garcia-Arumí J; Mateo C; Corcóstegui B
    J Ocul Pharmacol Ther; 2014 Nov; 30(9):709-16. PubMed ID: 25259834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluocinolone Acetonide Intravitreal Implant 190 μg (ILUVIEN®) in Vitrectomized versus Nonvitrectomized Eyes for the Treatment of Chronic Diabetic Macular Edema.
    Pessoa B; Coelho J; Correia N; Ferreira N; Beirão M; Meireles A
    Ophthalmic Res; 2018; 59(2):68-75. PubMed ID: 29248913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.
    Zur D; Iglicki M; Busch C; Invernizzi A; Mariussi M; Loewenstein A;
    Ophthalmology; 2018 Feb; 125(2):267-275. PubMed ID: 28935399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema.
    Vujosevic S; Torresin T; Bini S; Convento E; Pilotto E; Parrozzani R; Midena E
    Acta Ophthalmol; 2017 Aug; 95(5):464-471. PubMed ID: 27775223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and tolerability of the fluocinolone acetonide implant in patients with diabetic macular edema in UAE: 12-Month results.
    Elbarky AM
    Eur J Ophthalmol; 2021 Nov; 31(6):3196-3202. PubMed ID: 33426902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal steroids for macular edema in diabetes.
    Rittiphairoj T; Mir TA; Li T; Virgili G
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005656. PubMed ID: 33206392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of intravitreal dexamethasone implant in treatment naïve eyes with diabetic macular edema: Real world experience.
    Ratra D; Sharma U; Dalan D
    Eur J Ophthalmol; 2021 Jul; 31(4):1899-1906. PubMed ID: 32772850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema in a Real-World Clinical Setting.
    Maggio E; Sartore M; Attanasio M; Maraone G; Guerriero M; Polito A; Pertile G
    Am J Ophthalmol; 2018 Nov; 195():209-222. PubMed ID: 30098350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation of retinal sensitivity, visual acuity and central macular thickness in different types of diabetic macular edema].
    Yang XL; Zou HD; Xu X
    Zhonghua Yan Ke Za Zhi; 2013 Dec; 49(12):1081-8. PubMed ID: 24499694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone Intravitreal Implant for Chronic Diabetic Macular Edema Resistant to Intravitreal Bevacizumab Treatment.
    Totan Y; Güler E; Gürağaç FB
    Curr Eye Res; 2016; 41(1):107-13. PubMed ID: 25610946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VISUAL OUTCOMES IN PATIENTS WITH DIABETIC MACULAR EDEMA TREATED WITH DEXAMETHASONE IMPLANT IN ROUTINE CLINICAL PRACTICE.
    Urbančič M; Gardašević Topčić I; Matović K
    Acta Clin Croat; 2021 Dec; 60(4):602-608. PubMed ID: 35734494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Collaborative Retrospective Study on the Efficacy and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema: The European DME Registry Study.
    Rosenblatt A; Udaondo P; Cunha-Vaz J; Sivaprasad S; Bandello F; Lanzetta P; Kodjikian L; Goldstein M; Habot-Wilner Z; Loewenstein A;
    Ophthalmology; 2020 Mar; 127(3):377-393. PubMed ID: 31932090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.